Differences in Brain Derived Neurotrophic Factor Levels Between Chronic and Asymptomatic Pain Patients
Unknown statusNCT05736575
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
A case-control study will be conducted to analyze the differences in BDNF levels between patients with chronic pain and asymptomatic people.
Study details
- Official title
- Differences in Brain Derived Neurotrophic Factor Levels Between Chronic and Asymptomatic Pain Patients
- Conditions
- Interventions
- Genetic: BDNF analysis (Elisa KIT)
- Sponsor
- Universidad Autonoma de Madrid
- Collaborators
- Universidad Rey Juan Carlos
- Start date
- 2023-05-15
- Primary completion
- 2024-02-28
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * males and females aged 18 to 65 years with musculoskeletal pain for a minimum of 3 months * patients recruited by information pamphlets from the university clinic of the Rey Juan Carlos University, and CSEU La Salle * not having received physiotherapy treatment for this same process in the last 3 months. * ability to perform all the clinical tests and to understand the study process, as well as to obtain informed consent. Exclusion Criteria: * Systemic, neurological, oncological or inflammatory diseases; psychiatric pathologies, pregnancy, type II diabetes.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05736575